Deutsche Bank’s Vera Therapeutics VERA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$47.3M Buy
1,102,106
+569,640
+107% +$21.2M 0.01% 666
2026
Q1
$21.4M Buy
532,466
+185,040
+53% +$7.97M 0.01% 830
2025
Q4
$17.6M Sell
347,426
-286,394
-45% -$10.2M 0.01% 904
2025
Q3
$18.4M Buy
633,820
+28,807
+5% +$666K 0.01% 882
2025
Q2
$14.3M Sell
605,013
-287,846
-32% -$6.47M 0.01% 915
2025
Q1
$21.4M Buy
892,859
+82,483
+10% +$2.65M 0.01% 808
2024
Q4
$34.3M Buy
810,376
+43,832
+6% +$1.94M 0.01% 723
2024
Q3
$33.9M Buy
766,544
+131,184
+21% +$4.98M 0.01% 706
2024
Q2
$23M Sell
635,360
-1,634
-0.3% -$64.8K 0.01% 778
2024
Q1
$27.5M Buy
636,994
+3,309
+0.5% +$118K 0.01% 717
2023
Q4
$9.75M Buy
633,685
+617,654
+3,853% +$7.84M 0.01% 1011
2023
Q3
$220K Buy
16,031
+2,289
+17% +$39.3K ﹤0.01% 2725
2023
Q2
$221K Sell
13,742
-208
-1% -$1.88K ﹤0.01% 2831
2023
Q1
$108K Buy
13,950
+7,602
+120% +$58.7K ﹤0.01% 3293
2022
Q4
$123K Buy
6,348
+92
+1% +$1.67K ﹤0.01% 3231
2022
Q3
$133K Sell
6,256
-2,317
-27% -$43.4K ﹤0.01% 3179
2022
Q2
$116K Buy
8,573
+469
+6% +$8.18K ﹤0.01% 3455
2022
Q1
$191K Buy
8,104
+2,091
+35% +$45K ﹤0.01% 3298
2021
Q4
$161K Buy
6,013
+1,945
+48% +$43K ﹤0.01% 3480
2021
Q3
$71K Buy
+4,068
New +$72.7K ﹤0.01% 4024

Other funds holding VERA

Deutsche Bank's VERA Position: Q2 2026 in Review

Deutsche Bank increased its Vera Therapeutics (VERA) stake by 107% in Q2 2026, buying an estimated $21.2M and bringing the position to 1,102,106 shares worth $47.3M. The position accounts for 0.01% of the portfolio, ranked #666.

Deutsche Bank first reported a position in VERA in Q3 2021 and has held it in 20 quarters since. 220 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • Deutsche Bank held 1,102,106 shares of Vera Therapeutics worth $47.3M as of Q2 2026.
  • Deutsche Bank bought 569,640 Vera Therapeutics shares in Q2 2026, an estimated $21.2M.
  • Vera Therapeutics made up 0.01% of Deutsche Bank's portfolio in Q2 2026, its #666 holding.
  • Deutsche Bank first reported a position in Vera Therapeutics in Q3 2021 and has held it in 20 quarters since.
  • 220 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.